MERISCREEN HCV
MERISCREEN HCV is a single test device for the qualitative detection of antibodies to Hepatitis C in human blood sample
- DOUBLE ANTIGEN SANDWICH SITE IMMUNOASSAY
- HIGHLY PURIFIED RECOMBINANT ANTIGEN – CORE, NS3, NS4, NS5 USED
Benefits
01
Sensitivity > 99.5%
02
Specificity > 99 %
03
Results in 20 minutes
Indication
-
Primary Screening of Hepatitis C infection
Product Specifications
| Intended Use | One step qualitative immunochromatographic assay for detection of antibodies against HCV in human serum, plasma and whole blood |
| Principle | Double Antigen Sandwich site Immunoassay |
| Technique | Lateral Flow(ICT) |
| Detection | Antibodies to HCV (IgM, IgG and IgA) |
| Capture | Recombinant antigens - Core, NS3, NS4 and NS5 |
| Conjugate | Recombinant antigens - Core, NS3, NS4 and NS5 coupled with colloidal gold |
| Type of Specimen required | Serum, Plasma and Whole blood |
| Specimen Volume | 10 ml for Serum and Plasma; 20 ml for whole blood |
| Result interpretation time | 20 mintutes |
| Diagnostic Sensitivity | > 99.5% |
| Diagnostic Specificity | > 99% |
| Evaluations | National Institute of Biologicals |
Size Chart
Ordering Information
| Product Code | Material Description | Pack Size |
|---|---|---|
| RPDHCV-01 | MERISCREEN HCV | 50 Tests |
Clinical Data
Product IFU
Note: IFU will be displayed after MDR Certification